Etoposide

About

Therapy type: Chemotherapy

Therapy strategy: Topoisomerase inhibition

Mappings

NCI Thesaurus: Etoposide (ncit:C491)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) CD20 + Diffuse Large B-Cell Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
Sensitivity (+) CD20 + Burkitt Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
Sensitivity (+) CD30 + Hodgkin Lymphoma Brentuximab Vedotin, Cisplatin, Cytarabine, Etoposide
Sensitivity (+) CD30 +, HER2-negative Hodgkin Lymphoma Brentuximab Vedotin, Carboplatin, Etoposide, Ifosfamide
Sensitivity (+) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Carboplatin, Etoposide, Ifosfamide, Rituximab
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine
Sensitivity (+) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Interferon Alpha, Prednisolone, Rituximab
Sensitivity (+) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine